🇺🇸 FDA
Pipeline program

I124-NM404

CO02505

Phase 1 small_molecule completed

Quick answer

I124-NM404 for Non Small Cell Lung Cancer is a Phase 1 program (small_molecule) at Cellectar Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Cellectar Biosciences
Indication
Non Small Cell Lung Cancer
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials